Business
Bayer reaps benefits of demand for new cancer and kidney medicines
German pharmaceutical giant Bayer AG released its second quarter and half year 2024 earnings on Tuesday morning, with the company seeing an average performance in the second quarter, due to the agricultural market environment becoming tougher.
Business
Bayer shares plunge over weedkiller trial
Bayer shares plunged as much as 14 percent on Monday, losing about €12 billion in value, after newly acquired Monsanto was ordered to pay €250 million in damages in the first of possibly thousands of US lawsuits over alleged links between a weedkiller and cancer.